| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 73, 1002-1007, Copyright © 1991 by Endocrine Society
ARTICLES |
TL Wu, NE Soifer, WJ Burtis, LM Milstone and AF Stewart
Division of Endocrinology, West Haven Veterans Affairs Medical Center, Connecticut 06516.
While the gene and mRNA transcripts encoding PTH-related peptide (PTHrP) have been well characterized, the actual secretory form(s) of the peptide is unknown. Accordingly, synthetic and recombinant PTHrPs employed to date for biological and immunological characterization have necessarily been of arbitrary lengths. No prior evidence for glycosylation of PTHrPs has been described. To define the naturally occurring form(s) of this peptide secreted by human epidermal keratinocytes, we have affinity purified, using an anti-PTHrP-(1-36) antibody column, human PTHrP secreted under conditions of protease protection. Human keratinocyte-conditioned medium collected without measures to protect against proteolytic degradation contains multiple PTHrP immunoreactive and bioactive species. In contrast, under conditions of protease protection, human keratinocyte-conditioned medium contains a single 18,000 mol wt (Mr) form of the peptide. In contrast to recombinant and synthetic PTHrPs, which migrate as distinct, well focussed bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, this 18,000 Mr PTHrP displays the broad electrophoretic profile of a glycoprotein. Treatment of this peptide with trifluoromethanesulfonic acid, an agent that deglycosylates both O- and N-linked saccharides from their core proteins, shifted the Mr of the protein to approximately 10,000. In contrast, exposure of recombinant PTHrP-(1-141) to the same agent results in no change in electrophoretic mobility. These studies indicate that the 18,000 Mr species of PTHrP secreted by human epidermal keratinocytes is a glycoprotein.
This article has been cited by other articles:
![]() |
K.-D. Schluter, C. Katzer, K. Frischkopf, S. Wenzel, G. Taimor, and H. M. Piper Expression, Release, and Biological Activity of Parathyroid Hormone-Related Peptide From Coronary Endothelial Cells Circ. Res., May 12, 2000; 86(9): 946 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishigaki, Y. Ohsaki, E. Toyoshima, and K. Kikuchi Increased Serum and Urinary Levels of a Parathyroid Hormone-related Protein COOH Terminus in Non-Small Cell Lung Cancer Patients Clin. Cancer Res., June 1, 1999; 5(6): 1473 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text] |
||||
![]() |
L. L. Plawner, W. M. Philbrick, W. J. Burtis, A. E. Broadus, and A. F. Stewart Cell Type-specific Secretion of Parathyroid Hormone-related Protein via the Regulated versus the Constitutive Secretory Pathway J. Biol. Chem., June 9, 1995; 270(23): 14078 - 14084. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |